Opportunity Information: Apply for PAR 25 177

The National Institute of Mental Health (NIMH), part of the National Institutes of Health (NIH), is offering a discretionary grant opportunity titled "Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)" under funding opportunity number PAR 25-177 (CFDA 93.242). The program supports full-scale clinical trials using the R01 mechanism and is positioned as a major component of NIMH's broader set of funding announcements that cover the full pipeline of intervention development and testing. Applications are accepted through an original closing date of 2027-10-15.

The core purpose of this opportunity is to fund rigorous, adequately powered effectiveness trials that can directly inform real-world mental health practice. NIMH is looking for studies that tackle significant mental health problems where the results have clear potential to change or improve how interventions are delivered in community and routine care settings. The announcement emphasizes that supported trials should be designed to definitively answer primary research questions, rather than serving as exploratory pilots. Proposals are expected to be grounded in well-justified hypotheses supported by pilot or preliminary data, and they should be structured to examine not only whether an intervention works, but also how and for whom it works through planned analyses of mediators and moderators.

The NOFO supports two broad categories of clinical trials. First, it funds trials that test the effectiveness of optimized therapeutic and preventive interventions when delivered in community or practice settings, meaning interventions that are sufficiently developed and ready for real-world evaluation beyond tightly controlled efficacy contexts. Second, it funds trials that evaluate the effectiveness of mental health services interventions at multiple levels, including patient-level strategies, provider-level strategies, organizational changes, or broader system-level approaches. These services interventions should be aimed at improving key dimensions of care such as access to services, continuity of care, quality, equity, and/or value, with an emphasis on outcomes that matter for real-world service delivery.

A defining feature of this announcement is its alignment with NIMH's experimental therapeutics approach. In practical terms, NIMH expects effectiveness trials to explicitly test whether the intervention engages the proposed target(s) or mechanism(s) that are presumed to drive improvement. Depending on the type of intervention, those mechanisms could involve changes in clinical or functional outcomes for patients, changes in provider behavior, or measurable improvements in service access, engagement, retention, or continuity. The intent is to move beyond simple outcome comparisons and ensure that the trial design includes measurement and analytic plans that can evaluate whether the intervention is influencing the hypothesized mechanism and whether that mechanism is linked to meaningful improvements.

The grant uses the R01 clinical trial required framework, and it also references a collaborative R01 option to support multisite trials when multiple sites are needed to successfully complete the study. Multisite collaboration is encouraged when it is necessary to reach adequate sample size, speed recruitment, or increase participant diversity and representation, which can strengthen both the internal validity of the trial and the generalizability of the findings to varied real-world settings.

Eligibility is broad and includes many types of domestic and non-domestic organizations. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations (other than small businesses); and small businesses. The announcement also highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), faith-based or community-based organizations, eligible federal government agencies, regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations).

Overall, this opportunity is geared toward teams prepared to run full-scale, practice-relevant mental health clinical trials that combine strong real-world effectiveness questions with explicit testing of mechanisms, and that are built to deliver clear, actionable conclusions for clinical care and mental health service systems.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
  • This funding opportunity was created on 2024-11-26.
  • Applicants must submit their applications by 2027-10-15.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 25 177

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Mental Health Services

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Eswatini- Alumni Engagement Innovation Fund 2025

Previous opportunity: Addiction Medicine Fellowship Program

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 25 177

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 25 177) also looked into and applied for these:

Funding Opportunity
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) Apply for PAR 25 179

Funding Number: PAR 25 179
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required) Apply for PAR 25 178

Funding Number: PAR 25 178
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required) Apply for PAR 25 180

Funding Number: PAR 25 180
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) Apply for PAR 25 182

Funding Number: PAR 25 182
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required) Apply for PAR 25 181

Funding Number: PAR 25 181
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Health Services Research (R34 Clinical Trial Optional) Apply for PAR 25 192

Funding Number: PAR 25 192
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) Apply for PAR 25 193

Funding Number: PAR 25 193
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Health Services Research (R01 Clinical Trial Optional) Apply for PA 25 245

Funding Number: PA 25 245
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) Apply for PA 25 163

Funding Number: PA 25 163
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD (R01 Clinical Trial Not Allowed) Apply for RFA AG 24 049

Funding Number: RFA AG 24 049
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) Apply for PAR 25 188

Funding Number: PAR 25 188
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed Apply for RFA RM 24 012

Funding Number: RFA RM 24 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) Apply for PAR 25 216

Funding Number: PAR 25 216
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) Apply for PAR 25 215

Funding Number: PAR 25 215
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) Apply for PAR 25 271

Funding Number: PAR 25 271
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) Apply for PAR 25 270

Funding Number: PAR 25 270
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,050,000
Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed) Apply for PAR 25 300

Funding Number: PAR 25 300
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) Apply for PAR 25 269

Funding Number: PAR 25 269
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
PEPFAR Community Led Monitoring (CLM)-Zambia Apply for PCLM 2025

Funding Number: PCLM 2025
Agency: U.S. Mission to Zambia
Category: Health
Funding Amount: $115,000
USAID SUstaining Control of the HIV Epidemic through quality Services, resilient Systems, and Community Outreach (SUCESSO) _ Sofala & Niassa Apply for 72065625RFA00002

Funding Number: 72065625RFA00002
Agency: Mozambique USAID-Maputo
Category: Health
Funding Amount: $77,500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 25 177", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: